Skip to content
Screener

Arcturus Therapeutics ARCT Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$3.0MMiss by $148.5K
EPS-$0.84Beat by $0.16
Revenue estimate$3.1M
EPS estimate-$1.00

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$8.0M
EPS estimate-$0.67

FAQ

When did Arcturus Therapeutics report Q2 2026 earnings?
Arcturus Therapeutics (ARCT) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Arcturus Therapeutics's Q2 2026 revenue and EPS?
Arcturus Therapeutics reported revenue of $3.0M and eps of $-0.84 for Q2 2026.
Did Arcturus Therapeutics beat estimates in Q2 2026?
Revenue missed the consensus estimate of $3.1M by $148.5K. EPS beat the consensus estimate of $-1.00 by $0.16.
How did Arcturus Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 87.9% from $24.5M a year earlier and eps declined 147.1% from $-0.34.
Where can I find Arcturus Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193805-26-001039) and the 10-Q periodic report (0001193125-26-338090) directly on SEC EDGAR. The filing index links above go to sec.gov.